&nbsp;

Sep 2025

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Jun 2025

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Sep 2025

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Jul 2025

Regimen

IRIN+CETU; IRIN(Q2W)+CETU

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Cetuximab with Irinotecan - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

cetuximab,

irinotecan

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IRIN(Wx4); IRIN

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used:

irinotecan

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For relapsed and refractory Mantle Cell Lymphoma, according to clinical criteria

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according to specific criteria.

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

IRINTMZL

Cancer Type:

Sarcoma,

Ewing's

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

irinotecan,

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

IBRU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

Exceptional Access Program

iBRUtinib - For the treatment of patients with relapsed or refractory Waldenstrӧm Macroglobulinemia, as monotherapy, based on criteria

Drugs Used:

iBRUtinib

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to criteria

Drugs Used:

alectinib

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

AVEL

Cancer Type:

Skin,

Merkel Cell

Intent: Palliative

Funding:

New Drug Funding Program

Avelumab - Metastatic Merkel Cell Carcinoma

Drugs Used:

avelumab